Consequently activities of the GLP-1R effectors, PKA to inhibit channel activation (through ADP binding), and Epac to facilitate channel inhibition (through ATP binding), result in a coordinated potentiation of glucose-initiated cell membrane depolarization.
This compound binds to exposed hydrophobic patches on proteins; this binding results in an increase in ANS fluorescence.
Addition of positive charge to the peptide surface upon peptide binding results in an enhancement of the FPE fluorescence, Δ F [15].
The minor G allele has shown to significantly inhibit the binding of SP1, and this loss of binding results in an 80% reduction in transcriptional activity in multiple human immortalized cell lines (3).
However, the gltA1 (A258T) mutation greatly diminished NADH binding, resulting in an inability to saturate the enzyme within the range of detection in the binding assay, which extends up to ∼10 μM NADH (Dickinson, 1970).
In synaptotagmin-1, Ca2+ binding results in an electrostatic switch that changes the net charge from negative to positive and enables the Ca2+ binding domain to interact with and insert into the negatively charged membranes [ 36, 37].
The regulatory logic of EIN3 binding results in an up-regulation of the gibberellin response; GID receptors target DELLA repressors for degradation, which releases PIF3 from repression, resulting in the activation of the gibberellin transcriptional response.
SNF binding results in an overall increase in the magnitude of the CD signal of the RNA band centered at ∼265 nm, consistent with an increased level of base stacking.
Ligand binding results in an active dimeric conformation of EGFR; by either forming a complex with another EGFR (homodimerisation) or with one of the other ErbB family members (heterodimerisation) [ 13, 14].
The previous chromatin immunoprecipitation assay showed that BRCA1 interacted with the SIRT1 promoter region between 1354 and 1902 and this binding resulted in an elevated expression of SIRT1 (Wang et al, 2008).
